|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||
|
||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=sE23977CC-603F-11EF-8E15-741485CE164B&I=39IZM&T=&OP=Display&O=html&O1=15880480&O2=2320000000019039&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DAntitumour%2520activity%2520and%2520tolerability%2520of%2520an%2520EphA2-targeted%2520nanotherapeutic%2520in%2520multiple%2520mouse%2520models%26rft.au%3DKamoun%252C%2520Walid%2520S%26rft.date%3D2019-04-01%26rft.eissn%3D2157-846X%26rft.externalDocID%3D30952988%26rft.genre%3Darticle%26rft.issue%3D4%26rft.jtitle%3DNature%2520biomedical%2520engineering%26rft.spage%3D264%26rft.volume%3D3%26rft_id%3Dinfo%253Adoi%252F10.1038%252Fs41551-019-0385-4%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-PROQUEST_CENTRAL-getFullTxt-object,2-TECHNOLOGY_COLLECTION-getFullTxt-object,3-DOI-getDOI-object,4-COBIB_SI_LCL-getHolding-object,5-REFWORKS_EXPORT_TOOL-getReference-object,6-GOOGLE_SCHOLAR_FREE-getWebSearch-object,7-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.187404&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15880480-sE23977CC-603F-11EF-8E15-741485CE164B" timestamp="2024-08-22T06:34:57Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:2320000000019039</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models</jnl:atitle>
<jnl:jtitle>Nature Biomedical Engineering</jnl:jtitle>
<jnl:date>2019-04-00</jnl:date>
<jnl:spage>264</jnl:spage>
<jnl:epage>280</jnl:epage>
<jnl:issn>2157-846X</jnl:issn>
<jnl:volume>3</jnl:volume>
<jnl:issue>4</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2157-846X</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:3911bd86f10d09b8b2d22e9407cac3b3b837eef6</ctx:identifier>
<ctx:identifier>urn:UUID:sE23977CC-603F-11EF-8E15-741485CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)